Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Escitalopram Oxalate Tablets
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Esketamine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anesthesia
1 trial -
Esketamine nasal spray
United Therapeutics Europe Ltd
Depression
1 trial -
Esketamine-lidocaine group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Chronic Pain
1 trial -
Etomidate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Complications
1 trial -
Exclusive Enteral Nutrition Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Crohn's Disease
1 trial -
Exforge HCTยฎ or Three Individual drug amlodipine + valsartan + hydrochlorothiazide
The University of Hong Kong
Intracerebral Hemorrhage
1 trial -
Exparel block in arthroscopic shoulder surgery
Pacira Ireland Limited
Injury of Shoulder Region
1 trial -
FAST Technique
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ST-Segment Elevation Myocardial Infarction
1 trial -
FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Biliary Tract Neoplasms
1 trial -
Fecal Microbiota Transplantation (FMT)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 1 Diabetes
1 trial -
Fenugreek Seeds Extract
Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
Hypogonadism
1 trial -
Ferric carboxymaltose
United Therapeutics Europe Ltd
Iron Deficiency
1 trial -
Ferrous Fumarate Oral Tablet
Hospital Authority, Hong Kong
Iron Deficiency Anemia Treatment
1 trial -
Fluoxetine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Fluoxetine
United Therapeutics Europe Ltd
Depression - Major Depressive Disorder
1 trial -
Fluoxetine
The University of Hong Kong
Depression
1 trial -
Forced administration of furosemide
The First People's Hospital of Lianyungang
Cytoreductive Surgery
1 trial -
Fosinopril
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus
1 trial -
Fuzheng 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acquired Immune Deficiency Syndrome Virus
1 trial -
Fuzheng 3
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acquired Immune Deficiency Syndrome Virus
1 trial -
G-CSF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Intrauterine Adhesion
1 trial -
GD007 Low-dose drug group
The First People's Hospital of Lianyungang
Moderate-Severe Intrauterine Adhesions
1 trial -
GLP-1 Receptor Agonists
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Short Bowel Syndrome (SBS)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources